Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

monoclonal

monoclonal is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 44
News articles 0
Drug details — monoclonal
Class
—
Route
—
Patents
20
Programs
44
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

monoclonal is an FDA-listed pharmaceutical active ingredient.

Key facts

INN monoclonal

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. ALXN2220-ATTRCM-301 Phase 3 · Alexion Europe SAS · Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
  2. KT-US-679-0788 Phase 3 · Anaxis Pharma · Relapsed/refractory multiple myeloma in patients who have re
  3. Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg Phase 3 · Sunshine Guojian Pharmaceutical · Acute Gout
  4. ziltivekimab, Ziltivekimab Phase 3 · NovoThirteen · The medical condition we are investigating is type 1 AMI (ST
  5. 201 Phase 2 · Y-mAbs Therapeutics · Treatment of high-risk neuroblastoma patients with primary r
  6. 2020-S112 Phase 2 · Chinese Academy of · Uterine Cervical Neoplasm
  7. Anti-CD40 Agonist Monoclonal Antibody CDX-1140 Phase 2 · United Therapeutics Europe · Ovarian Clear Cell Adenocarcinoma
  8. Anti-human CCL24 monoclonal antibody (CM-101) Phase 2 · Chemomab Therapeutics · Primary Sclerosing Cholangitis

Related patents

Browse patents

  1. US 12415866

    Monoclonal antibody inhibitor of Factor XIIa

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12358971

    Arena virus monoclonal antibodies and uses

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12344676

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12331110

    Monoclonal antibodies against endotrophin and the use thereof

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12275781

    Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12152071

    EGFL6 specific monoclonal antibodies and methods of their use

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12122843

    High affinity monoclonal antibodies targeting glypican-1 and methods of use

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12077572

    Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12037401

    Anti-TrkB monoclonal antibodies and methods of use

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12012463

    High affinity monoclonal antibodies targeting glypican-2 and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12012455

    Human monoclonal antibodies specific for FLT3 and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11952429

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11939377

    Affinity matured CD22-specific monoclonal antibody and uses thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11896654

    DNA monoclonal antibodies targeting checkpoint molecules

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11891436

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11866503

    Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11851477

    DNA monoclonal antibodies targeting influenza virus

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11767367

    Monoclonal antibody neo-201 for the treatment of human carcinomas

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11760795

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11680093

    Monoclonal antibodies that specifically bind to matrilin 3 and their use

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is monoclonal?

monoclonal is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.